ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,416,051, issued on Sept. 16, was assigned to The Francis Crick Institute Ltd. (London) and University College London (London).

"Method of predicting survival rates for cancer patients" was invented by Robert Charles Swanton (London), Dhruva Biswas (London), Nicholas McGranahan (London) and Nicolai Juul Birkbak (Aarhus, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a method for providing a prognosis for a subject with lung cancer, the method comprising: (a) contacting a biological sample from the subject with reagents that specifically bind to each member of a panel of biomarkers comprising ANLN, ASPM, CDCA4, ERRF...